Triple-negative breast cancer (TNBC) represents a particularly aggressive subtype of breast cancer (BC), characterized by the absence of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor-2 (HER2)1. This evidence concerns the gene ERBB2 and breast cancer.